Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Comera Life Sciences Holdings, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   10-K10-KS-1
Revenues:  
    Customer Three  0.6  
    Customer Two   0.3 
Total revenues  0.60.30.4
            Revenue growth  97.9%-27.8% 
Cost of goods sold  0.20.20.1
Gross profit  0.40.20.3
            Gross margin  66.8%49.7%76.4%
Selling, general and administrative   [+]10.73.91.2
Research and development  1.71.81.3
EBITDA   [+]-11.9-5.4-2.0
            EBITDA margin  -1875.9%-1703.9%-460.1%
Depreciation and amortization  0.10.10.1
EBIT   [+]-12.0-5.5-2.1
            EBIT margin  -1890.7%-1730.8%-480.3%
Interest expense  0.0  
Other income (expense), net   [+]12.05.52.1
Pre-tax income  0.00.00.0
Income taxes  0.00.00.0
Net income  -18.0-5.5-2.1
            Net margin  -2843.8%-1704.6%-479.9%
   
Basic EPS   [+]($1.72)($1.81)($0.25)
Diluted EPS   [+]($1.72)($1.81)($0.25)
   
Shares outstanding (basic)   [+]10.53.08.5
Shares outstanding (diluted)   [+]10.53.08.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy